Total and phosphorylated tau protein as biological markers of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

http://www.wikidata.org/entity/Q33624674

about

Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Body fluid biomarkers in Alzheimer's disease Cerebrospinal fluid and blood biomarkers in Alzheimer's disease Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope Recognition Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.Test and Evaluation of ff99IDPs Force Field for Intrinsically Disordered Proteins.Cerebrospinal fluid analysis should be considered in patients with cognitive problems Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Hyperphosphorylation and cleavage at D421 enhance tau secretion Identifying and validating biomarkers for Alzheimer's disease.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease.Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease Alzheimer's Disease: Lessons Learned from Amyloidocentric Clinical Trials.Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression Amyloid-β associated volume loss occurs only in the presence of phospho-tau.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.A correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.Fluid biomarkers in Alzheimer's disease - current concepts Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

P2860

Q26749755-DE00BA65-382E-49BA-9AEB-6D75F0C38485 Q26830098-A136A897-BA80-4EE5-8389-559C569B2034 Q27023758-99F9EC5F-E2A6-45F9-A1F6-D5B864DD5B9F Q27024518-88AD5380-FBA7-47DA-AE51-F2D43396C643 Q27316185-49044A75-ECB9-46FF-9BD9-753FA9FF67E0 Q27675104-666104A6-ECE4-4B1F-8FB2-B382321A157B Q29417147-664C9C24-6FC0-4F6C-BFBF-8D5340F7E459 Q30235315-A1C5F62C-F3FE-41CD-AEFF-9DA7642E3F10 Q30996799-A76F05F5-1BDA-4F6F-8B15-6D504D280E48 Q33689233-6FBEC8E7-3234-4C1F-AE28-FB474C18D676 Q33756751-9BDFCC79-EDA5-461B-A7E0-A403906B4AE9 Q33842486-0D3D43C0-95CA-46F2-9B01-AA114D034EF0 Q33851634-12CE8D59-8FFB-4C01-BB03-670573BC952A Q34026659-939796ED-4168-4C30-8EF5-786A8013C723 Q34043074-9DFFECA4-F90F-4F6D-A24A-BD798C9695D2 Q34157882-3DD5F5D1-ECC8-48D4-87C4-62DF1E55AE56 Q34183016-F18CB140-E390-42D6-B0F2-0E43B4441CEA Q34277477-D0591F04-761E-409E-A88B-9AD6B9DA8582 Q34468961-9C0AA93E-2883-4D7F-94EA-68D9AB0897CA Q34776835-88DB0E51-8D47-43B2-9F67-BD111F01A28B Q35029908-11F03B34-18CA-4111-B8C5-AF100B35D205 Q35034827-44F9F202-EE3F-4B93-9113-F13C613565CD Q35166684-FF51842D-306E-4E5E-95EF-F4F750664E24 Q35218413-E5F45FDF-77D5-4F2D-A79C-A5D5DFD84C33 Q35540628-DE99F372-0E23-425D-BC90-6B952E57B072 Q35695716-92740081-F735-4AC6-BE16-4CC288E61F87 Q35775390-E4BCDC83-6B00-4BDD-A793-35047E2E36DC Q36010484-CE8A8BE7-AE61-40CC-B3AA-BBE0C7CAA6F8 Q36165011-C5C0E77A-47C1-4A8B-8392-A1FEAEB2B6FE Q36177140-A042A962-6456-4CD3-AE54-BC9A01512B89 Q36209423-FE948CD5-D2D7-4B16-8DF1-63158F1D6EB2 Q36307607-A635EA3D-D83A-4B60-A3A0-6DE554EB1EDC Q36328476-41D2E601-3C4E-48B9-AB91-127CAA02DC49 Q36412536-A714A4F6-66AA-43CE-AD47-3C478A4E4E2E Q36433310-66572330-E737-447C-87FE-12BFECB59860 Q36626657-6E78933F-DECE-401F-8967-9A599106D737 Q36913222-4F4E35AB-78C8-4007-9A1A-B71A3A734EE2 Q36953503-57B5B258-E329-4721-84FE-2DA738D98533 Q37130046-A9DF1536-2D1C-4AFA-AD3E-D0E3433E6881 Q37410700-0A361ADC-32EA-4BCF-94DD-A2C20DBDAD96

P2860

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

http://www.wikidata.org/entity/Q33624674

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@ast

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@en

type

label

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@ast

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@en

prefLabel

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@ast

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@en

P1433

Q33624674-14AF9D5E-D49B-4B4E-ACE3-E64E72C84F82

P1476

Q33624674-E82B4078-B27C-4039-B4EB-D2269B7FA9A7

P2093

Q33624674-0BC785AE-8635-46DA-958C-F415217E601C

Q33624674-3A28D27E-88C8-40BB-8839-EDCD7D554F21

P2860

Q33624674-04771888-240A-4A9F-BF4D-EF033D3D66B4

Q33624674-05EBA7B9-ABA1-4FD0-A23C-D707FC602251

Q33624674-06EF8E25-9618-4B6C-871B-2A7BF4FE3E4C

Q33624674-06F89729-7796-43AD-9FCB-EC18B3212722

Q33624674-12D64011-03F4-42C1-899C-B5B173C0081A

Q33624674-132DFB9C-834B-4CA8-902E-C0E49948C4DA

Q33624674-14878F43-2777-4E2F-A6B7-44D7A09D5BED

Q33624674-14902A5D-BBBF-4A4A-A07A-AFA6F028DA5B

Q33624674-1614A0C7-129A-4D02-9039-9E59E2DB3812

Q33624674-17B14D93-45D0-49C5-A758-9316ABA83922

P304

Q33624674-754FB865-F7F2-491F-A76B-3A45F9A1320C

P31

Q33624674-EA34B477-BB7F-45F9-828B-FD664E6E6B57

P356

Q33624674-6D21A828-A0EB-46B3-989A-13F2219062AE

P433

Q33624674-3C9AE048-05B8-46D0-8EAC-DB2C6196CCED

P478

Q33624674-BCE9C1ED-D80C-4179-A5E2-57AAFE8C9E3D

P50

Q33624674-201D08EB-E9FB-4EAC-A84D-7C9B13ABCD0C

Q33624674-2316FE79-B743-46C5-AB2E-59A431BDC1EF

Q33624674-24C611FB-D131-4CB7-B3CE-80A9CF933FC8

Q33624674-E5771FD5-BC53-4EA4-A3B9-E30DF907C267

P577

Q33624674-0BC9C2CE-1DF9-4F9A-BB52-3505D1788CEF

P5875

Q33624674-0CD24D9D-1D8B-4132-8448-C6CA70711102

P698

Q33624674-2B84856F-ABA4-4AC7-A4F1-38484DC04F8E

P921

Q33624674-431B48FC-136B-41CC-BA90-85B90FC3CC20

Q33624674-517B4CB9-C260-4AA8-AE65-38CD448EFB29

P932

Q33624674-D040DD9C-FAD3-47F7-BFF9-A9569B2F6737

P356

J.EXGER.2009.10.010

P1433

Experimental Gerontology

P1476

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

@en

P2093

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Yvonne C Hoessler

http://www.w3.org/2001/XMLSchema#string

P2860

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

Alzheimer's disease

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Blood-based biomarkers of microvascular pathology in Alzheimer's disease.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

P304

30-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXGER.2009.10.010

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

John Q. Trojanowski

P577

2009-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38033114

http://www.w3.org/2001/XMLSchema#string

P698

19853650

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

phosphorylation

P932

2815003

http://www.w3.org/2001/XMLSchema#string